Biosimilar Clinical Development: Scientific Considerations and New Methodologies (Hardcover)

Biosimilars have the potential to change the way we think about, identify, and manage health problems. They are already impacting both clinical research and patient care, and this impact will only grow as our understanding and technologies improve. Written by a team of experienced specialists in clinical development, this book discusses various potential drug development strategies, the design and analysis of pharmacokinetics (PK) studies, and the design and analysis of efficacy studies.

General

Imprint:	Apple Academic Press Inc.
Country of origin:	Canada
Series:	Chapman & Hall/CRC Biostatistics Series
Release date:	2017
Editors:	Kerry B. Barker • Sandeep M. Menon • Siyan Xu • Ralph B. D'Agostino, Sr. • Bo Jin, PhD
Dimensions:	234 x 156 x 16mm (L x W x T)
Format:	Hardcover
Pages:	248
ISBN-13:	978-1-4822-3169-4
Categories:	Books > Medicine > General issues > Public health & preventive medicine > Epidemiology & medical statistics Books > Medicine > Other branches of medicine > Pharmacology > General
LSN:	1-4822-3169-7
Barcode:	9781482231694

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!